Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-524-281"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-524-281"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-524-2962
lpv:speaker	lp:Nuno Melo2
lpv:spokenAs	member_of_the_bureau; EPP (2009-07-14--2014-06-30)3 substitute; DROI (2012-01-19--2014-06-30)3 vice-chair; Delegation for relations with the Mercosur countries (2009-09-30--2014-06-30)3 member; LIBE (2012-01-19--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 substitute; ECON (2012-01-19--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"The EU is an area of solidarity which offers the European Globalisation Adjustment Fund (EGF). This support is vital to help the unemployed and victims of the relocations that occur in a globalised context. The number of undertakings which are relocating is constantly on the increase, due to their taking advantage of the cheaper labour costs which are available in various countries, particularly China and India, to the detriment of those countries which respect workers’ rights. The EGF is intended to help workers suffering the consequences of relocations, and it is vital to facilitate access to a new job. In the past the EGF has been used by other countries in the EU. This support must now be given to Sweden, which has submitted an application for assistance for 987 redundancies, of which 700 are targeted for assistance, in the pharmaceutical company AstraZeneca in Sweden."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph